A multicenter, double-blind, randomized, placebo-controlled, parallel study of the safety and efficacy of BOTOX (botulinum toxin type A) purified neurotoxin in the treatment of focal upper limb spasticity poststroke

被引：0
|
作者：
Brashear, A
Gordon, MF
Elovic, E
Kassicieh, D
Marciniak, C
Turkel, C
Do, M
Jenkins, SW
机构：
来源：
NEUROLOGY | 2001年 / 56卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A78 / A78
页数：1
相关论文
共 50 条
  • [31] Botulinum Toxin Type A for the Treatment of Glabellar Lines in Chinese: A Double-Blind, Randomized, Placebo-Controlled Study
    Wu, Yan
    Zhao, Guang
    Li, Hengjin
    Zheng, Zhizhong
    Zhong, Shaomin
    Yang, Zhiyong
    Feng, Zheng
    Yang, Qinping
    Zhu, Xuejun
    DERMATOLOGIC SURGERY, 2010, 36 (01) : 102 - 108
  • [32] Botulinum toxin type-A in the prophylactic treatment of medication-overuse headache: a multicenter, double-blind, randomized, placebo-controlled, parallel group study
    Giorgio Sandrini
    Armando Perrotta
    Cristina Tassorelli
    Paola Torelli
    Filippo Brighina
    Grazia Sances
    Giuseppe Nappi
    The Journal of Headache and Pain, 2011, 12 : 427 - 433
  • [33] Botulinum toxin type-A in the prophylactic treatment of medication-overuse headache: a multicenter, double-blind, randomized, placebo-controlled, parallel group study
    Sandrini, Giorgio
    Perrotta, Armando
    Tassorelli, Cristina
    Torelli, Paola
    Brighina, Filippo
    Sances, Grazia
    Nappi, Giuseppe
    JOURNAL OF HEADACHE AND PAIN, 2011, 12 (04): : 427 - 433
  • [34] Multicenter, randomized, double-blind, placebo-controlled, parallel trial comparing the safety and efficacy of rufinamide
    Biton, V
    Rosenfeld, W
    Schachter, S
    Perdomo, C
    Arroyo, S
    ANNALS OF NEUROLOGY, 2005, 58 : S114 - S114
  • [35] Botulinum neurotoxin type a for treatment of chronic migraine: double-blind, randomized, placebo-controlled PREEMPT trials
    Dodick, D. W.
    Aurora, S. K.
    Turkel, C. C.
    DeGryse, R. E.
    Silberstein, S. D.
    Lipton, R. B.
    Diener, H. -C.
    Brin, M. F.
    CEPHALALGIA, 2009, 29 (12) : 1350 - 1350
  • [36] Efficacy and Safety of Botulinum Toxin Type A in the Treatment of Glabellar Lines: A Meta-Analysis of Randomized, Placebo-Controlled, Double-Blind Trials
    Guo, Yu
    Lu, Yongzhou
    Liu, Tianyi
    Zhou, Yiqun
    Yang, Ping
    Zhu, Jingjing
    Chen, Liang
    Yang, Qingjian
    PLASTIC AND RECONSTRUCTIVE SURGERY, 2015, 136 (03) : 310E - 318E
  • [37] GOAL ATTAINMENT SCALING IN THE EVALUATION OF TREATMENT OF UPPER LIMB SPASTICITY WITH BOTULINUM TOXIN: A SECONDARY ANALYSIS FROM A DOUBLE-BLIND PLACEBO-CONTROLLED RANDOMIZED CLINICAL TRIAL
    Turner-Stokes, Lynne
    Baguley, Ian J.
    De Graaff, Stephen
    Katrak, Pesi
    Davies, Leo
    McCrory, Paul
    Hughes, Andrew
    JOURNAL OF REHABILITATION MEDICINE, 2010, 42 (01) : 81 - 89
  • [38] The efficacy of Dysport® (botulinum toxin type A) in the treatment of cervical dystonia:: A phase III multicenter, randomized, double blind, placebo-controlled study
    Truong, D.
    Lew, M.
    Orlova, P. O.
    MOVEMENT DISORDERS, 2008, 23 (01) : S175 - S175
  • [39] The therapeutic effect of botulinum toxin on tension-type headache: a multicenter, randomized, double-blind, placebo-controlled study
    Schulte-Mattler, WJ
    Krack, P
    CEPHALALGIA, 2003, 23 (07) : 634 - 634
  • [40] The therapeutic effect of botulinum toxin on tension-type headache: a multicenter, randomized, double-blind, placebo-controlled study
    Schulte-Mattler, W
    Krack, P
    JOURNAL OF NEUROLOGY, 2004, 251 : 41 - 41
12345